Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$2,928,782
+$246,787 QoQ
Shares Held
11,532
+5.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.80%
of 13F equity value
Holder Rank
#2,026
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Valley Brook Capital Group, Inc. holds $13,706,850 across 7 Drug Manufacturers - General names. JNJ ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
23,146 | $5,824,459 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
11,532 | $2,928,782 | |
| 3 | LLY |
ELI LILLY & Co
|
1,625 | $1,949,073 | |
| 4 | AMGN |
Amgen Inc
|
4,243 | $1,536,475 | |
| 5 | NVS |
Novartis AG
|
4,717 | $739,248 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,770 | $390,087 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,636 | $338,726 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,928,782 | 11,532 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $2,681,995 | 10,972 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,254,099 | 10,892 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,018,667 | 10,887 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,684,068 | 11,025 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,828,386 | 11,025 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,745,708 | 12,071 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $1,996,093 | 12,317 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $1,910,018 | 13,068 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $2,091,746 | 13,223 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,080,410 | 13,273 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,082,844 | 13,373 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $2,213,498 | 13,373 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,289,815 | 14,773 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,627,668 | 14,875 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,429,980 | 14,875 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $2,640,461 | 14,875 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,636,296 | 14,875 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,544,666 | 14,875 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $2,402,312 | 14,875 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $2,458,744 | 14,925 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $2,448,650 | 14,899 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,303,413 | 14,636 | Shares | Sole | 2021-03-19 | |
| No filing history on record for this holder in this stock. | ||||||